NEW YORK (GenomeWeb News) – Prodesse has licensed Invitrogen’s LUX PCR reagents for use in molecular diagnostics, the companies said on Friday.
 
The agreement marks the first use of the LUX (Light Upon eXtension) PCR chemistries in diagnostic assays, the companies said.
 
Invitrogen said that the LUX reagents can be used in gene expression studies, biomarker analysis, and functional genomics experiments and enable users to examine multiple targets in one experiment.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.